Patent reform being used as bargaining chip at expense of Canadians’ health.
VANCOUVER, BC, August 23, 2012: The Conservative government should remove patent reform from the negotiations of the Comprehensive Economic and Trade Agreement (CETA) with the European Union, says New Democrat Trade Critic Don Davies.
“Changing the patent regime for pharmaceuticals is a complicated issue with deep consequences for Canadians, provincial healthcare programs, and Canadian employers,” said Davies (Vancouver-Kingsway). “Studies project the patent extensions proposed by the EU could raise Canadians’ drug costs by $2.8 billion a year.”
Drug costs are the second leading health care costs for provinces and are rising every year. A recent report reveals that many low income Canadians cannot afford the cost of their medicines and one in four are simply not filling their prescriptions.